Yüklüyor......
Review and perspective on adjuvant and neoadjuvant immunotherapies in NSCLC
Postoperative patients have risk recurring, even for completed resected early stage non-small-cell lung cancer (NSCLC). To control the recurrence rate, neoadjuvant and adjuvant therapies have been applied widely in clinical practice; however, neoadjuvant and adjuvant immunotherapy clinical trials on...
Kaydedildi:
| Yayımlandı: | Onco Targets Ther |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6735538/ https://ncbi.nlm.nih.gov/pubmed/31564915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S218321 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|